Heparin Sodium Injection
Product Images NDC 0069-0043

12 FDA label images from Pfizer Laboratories Div Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Heparin Sodium (NDC 0069-0043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Heparin 01)

Chemical Structure (Heparin 01)
Chemical structure of Heparin Sodium, showing the molecular arrangement and functional groups characteristic of this anticoagulant active ingredient.*
FDA Label Image

Logo (Heparin 02)

FDA Label Image

Principal Display Panel (10,000 USP units/10 mL Multidose Vial Label)

Principal Display Panel (10,000 USP units/10 mL Multidose Vial Label)
Heparin Sodium Injection, USP label for a multidose vial from Pfizer Laboratories. The label indicates a strength of 10,000 USP units per 10 mL (1,000 USP units/mL). It specifies use for subcutaneous or intravenous administration, derived from porcine intestinal tissue, and includes a warning that the product contains benzyl alcohol.*
FDA Label Image

Principal Display Panel (10,000 USP units/10 mL Multidose Vial Carton)

Principal Display Panel (10,000 USP units/10 mL Multidose Vial Carton)
Packaging label for Heparin Sodium Injection, USP, 10,000 USP units per 10 mL (1,000 USP units per mL), in a carton designed to hold twenty-five 10 mL multidose vials. The label includes warnings about containing benzyl alcohol, instructions against use for lock flush, and notes the product is derived from porcine intestinal tissue. Labeled by Pfizer Laboratories Div Pfizer Inc, with barcode and storage instructions visible.*
FDA Label Image

Principal Display Panel (50,000 USP units/10 mL Multidose Vial Label)

Principal Display Panel (50,000 USP units/10 mL Multidose Vial Label)
Heparin Sodium Injection, USP label for a multidose vial with a strength of 50,000 USP units per 10 mL (5,000 USP units/mL). The label includes warnings that the product is not for lock flush, is for subcutaneous or intravenous use, contains benzyl alcohol, and is derived from porcine intestinal tissue. Distributed by Pfizer Labs, Division of Pfizer Inc, New York, NY.*
FDA Label Image

Principal Display Panel (50,000 USP units/10 mL Multidose Vial Carton)

Principal Display Panel (50,000 USP units/10 mL Multidose Vial Carton)
Label for Heparin Sodium Injection USP by Pfizer Laboratories, strength 50,000 USP units/10 mL (5,000 USP units per mL). The label indicates it is for multiple 10 mL vials, derived from porcine intestinal tissue, for subcutaneous or intravenous use. Packaging highlights the presence of benzyl alcohol and cautions it is not for lock flush use.*
FDA Label Image

Principal Display Panel (1 mL Multidose Vial Label Multidose Vial Label)

Principal Display Panel (1 mL Multidose Vial Label Multidose Vial Label)
Label for Heparin Sodium Injection, USP 10,000 USP units/mL in a multidose vial. The label indicates the product is for subcutaneous or intravenous use, derived from porcine intestinal tissue, and distributed by Pfizer Laboratories Division of Pfizer Inc, New York, NY. The label includes a warning for benzyl alcohol content and states Rx only.*
FDA Label Image

Principal Display Panel (1 mL Multidose Vial Carton)

Principal Display Panel (1 mL Multidose Vial Carton)
Heparin Sodium Injection USP 10,000 USP units/mL multi-dose vial carton from Pfizer Laboratories. The carton includes warnings that the product contains benzyl alcohol and is not for lock flush. It indicates use for subcutaneous or intravenous administration and states that the heparin is derived from porcine intestinal tissue. Storage instructions and dosage references are noted along with barcode and manufacturer information.*
FDA Label Image

Principal Display Panel (2 mL Single Dose Vial Label)

Principal Display Panel (2 mL Single Dose Vial Label)
Label for Heparin Sodium Injection, USP, 2,000 USP units per 2 mL (equivalent to 1,000 USP units/mL), preservative-free single dose vial. Indicates use for subcutaneous or intravenous administration. Distributed by Pfizer Labs, Division of Pfizer Inc, NY. Includes lot number and usage instructions.*
FDA Label Image

Principal Display Panel (2 mL Single Dose Vial Carton)

Principal Display Panel (2 mL Single Dose Vial Carton)
Heparin Sodium Injection, USP 2000 USP units per 2 mL (1000 USP units per mL) packaging label for twenty-five 2 mL single dose vials. The label includes the Pfizer Injectables logo and states preservative-free with a warning 'NOT for Lock Flush.' Distributed by Pfizer Labs Division of Pfizer Inc.*
FDA Label Image

Principal Display Panel (30 mL Multidose Vial Label)

Principal Display Panel (30 mL Multidose Vial Label)
Heparin Sodium Injection, USP multidose vial label showing strength of 30,000 USP units per 30 mL (1,000 USP units/mL). The label indicates it is for subcutaneous or intravenous use, derived from porcine intestinal tissue, distributed by Pfizer Labs, Division of Pfizer Inc, NY. It carries warnings including 'Not for Lock Flush' and contains benzyl alcohol. The Pfizer Injectables logo is present.*
FDA Label Image

Principal Display Panel (30 mL Vial Carton)

Principal Display Panel (30 mL Vial Carton)
Packaging label for Heparin Sodium Injection, USP with a strength of 1,000 USP units per mL (total 30,000 USP units per 30 mL). The label indicates it is for subcutaneous or intravenous use, comes in multidose vials, and is distributed by Pfizer Laboratories Div Pfizer Inc. It includes warnings about benzyl alcohol and states the product is not for lock flush.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.